SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-003883
Filing Date
2022-02-11
Accepted
2022-02-11 08:15:43
Documents
47
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 717812
2 ex31-1.htm EX-31.1 13573
3 ex31-2.htm EX-31.2 13636
4 ex32-1.htm EX-32.1 9470
  Complete submission text file 0001493152-22-003883.txt   2868691

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aneb-20211231.xsd EX-101.SCH 22180
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aneb-20211231_cal.xml EX-101.CAL 27068
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aneb-20211231_def.xml EX-101.DEF 92168
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aneb-20211231_lab.xml EX-101.LAB 184922
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aneb-20211231_pre.xml EX-101.PRE 157908
41 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 346976
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40388 | Film No.: 22616862
SIC: 2834 Pharmaceutical Preparations